CD40 ligand
| GO Term | Evidence Code | PMID |
|---|---|---|
| regulation of immunoglobulin production |
|
|
| regulation of immune system process |
|
|
| positive regulation of immune response to tumor cell |
|
|
| inflammatory response |
|
|
| inflammatory response |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| Golgi apparatus |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine activity |
|
|
| cytokine activity |
|
|
| cytokine activity |
|
|
| tumor necrosis factor receptor binding |
|
|
| CD40 receptor binding |
|
| Gene Ontology |
|---|
| CD40 receptor binding |
| cytokine activity |
| immune response |
| tumor necrosis factor receptor binding |
| InterPro |
|---|
| CD40 ligand |
| Tumour necrosis factor domain |
| Tumour necrosis factor, conserved site |
| Tumour necrosis factor-like domain superfamily |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050589 | inflammatory bowel disease | |
| DOID:9074 | systemic lupus erythematosus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026